|
New Virtual Cybersecurity Lecture Series Starts November 18, 2021
The U.S. Food and Drug Administration (FDA) and the University of California San Francisco (UCSF) - Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) are pleased to announce a new lecture series.
The one-hour virtual lectures will cover cybersecurity concepts applied to medical devices and biomedical engineering. Examples of topics covered include human factors for cybersecurity, trustworthy medical device software, security engineering for machine learning, cybersecurity of computer vision, threat modeling, software bill of materials, cybersecurity regulations, and the science behind cybersecurity.
-
Lecture Title: Innocence and Experience: Regulatory Tales
-
Speaker: Carl Landwehr, PhD, University of Michigan
-
Topic Areas: Building construction, automobiles, airplanes, cybersecurity
-
Date: Thursday, November 18, 2021
-
Time: 12:00 – 1:00 p.m. EST
-
Location: Virtual via Zoom. Link to join will be sent to registered attendees.
-
Registration Deadline: Registration is required and closes after the first 1,000 registrants.
|
The live talks are geared toward the academic and manufacturing communities. After each talk, CERSI will post a recording of the talk and Q/A will be posted on the seminar series website and the UCSF-Stanford CERSI’s YouTube channel.
For details on the FDA CERSI program, see Centers of Excellence in Regulatory Science and Innovation.
Questions?
If you have questions about this seminar series, contact Lawrence Lin, PhD (Lawrence.Lin@ucsf.edu) and Kevin Fu, PhD (Kevin.Fu@fda.hhs.gov).
|
